The NeuroSAFE PROOF trial, run across five UK hospitals, is the first randomized, controlled trial to fully evaluate the ...

Bright Uro announced today that it has received FDA 510(k) clearance for its Glean urodynamic analyzer system.

Searching for effective treatment options for 'Urinary Retention symptom'? This page is a valuable resource, featuring a complete guide to the latest medications-both generic and branded-ideal for ...

Baseline prostate volume declined by about 50% with aquablation versus 75% with LEP, which was associated with greater ...

HIV doesn’t cause urinary symptoms on its own but may increase your risk of a health condition, such as a urinary tract infection or kidney damage, that can lead to symptoms. Living with HIV can ...

Bright Uro, a medical device company with a mission to transform care for lower urinary tract dysfunction (LUTD) through innovations in urodynamics, today announced that the U.S. Food and Drug ...

Urinary incontinence responders demonstrated ... SNS is a viable option for treating bladder and bowel dysfunction in this patient population Haddad et al. 4 are to be commended for their well ...

NeuroSAFE was associated with reduced urinary incontinence at 3 months ... fewer patients treated with NeuroSAFE had severe erectile dysfunction (38% vs 56% with standard RARP) while more patients ...